Home › Cardiovascular Disease › New Hampshire
Cardiovascular Disease clinical trials in New Hampshire
4 studies for Cardiovascular Disease are looking for participants at sites in New Hampshire.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Portsmouth
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07181109Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565Zenith® Fenestrated+ Clinical Study
- Dartmouth-Hitchcock Medical Center, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT04875429A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.